Complete Blood Count Ratios Predict Adverse Events After Total Joint Arthroplasty.
Ian A JonesJulian WierMatthew S ChenKevin C LiuRyan PalmerCory K MayfieldNathanael D HeckmannPublished in: The Journal of the American Academy of Orthopaedic Surgeons (2024)
Given CBRs' ability to both predict outcomes and identify patients with a proinflammatory phenotype, the findings of this study provide a framework for future investigations aimed at identifying and treating high-risk patients with immune-modulating therapies. Continued work to validate these findings by applying TVs to interventional clinical trials is needed before wide clinical adoption.